Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
7.74M
-
Number of holders
-
10
-
Total shares
-
444K
-
Shares change
-
+39.7K
-
Total reported value, excl. options
-
$3.74M
-
Value change
-
+$267K
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$8.44
Significant Holders of Kazia Therapeutics Limited - American Depositary Shares (KZIA) as of Q4 2021
10 filings reported holding KZIA - Kazia Therapeutics Limited - American Depositary Shares as of Q4 2021.
Kazia Therapeutics Limited - American Depositary Shares (KZIA) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 444K shares
of 7.74M outstanding shares and own 5.74% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (299K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (50.8K shares), SG Americas Securities, LLC (34.1K shares), ENVESTNET ASSET MANAGEMENT INC (26.4K shares), RENAISSANCE TECHNOLOGIES LLC (22.4K shares), SIMPLEX TRADING, LLC (7.51K shares), UBS Group AG (3.05K shares), WELLS FARGO & COMPANY/MN (500 shares), Steward Partners Investment Advisory, LLC (100 shares), and DEUTSCHE BANK AG\ (0 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.